市场调查报告书
商品编码
1625225
到 2030 年内视镜手术设备市场预测:按产品类型、使用类型、应用、最终用户和地区进行的全球分析Endoscopy Operative Devices Market Forecasts to 2030 - Global Analysis By Product Type (Energy Systems, Access Devices, Suction & Irrigation Systems and Other Product Types), Usage Type (Reusable and Disposable), Application, End User and By Geography |
根据Stratistics MRC预测,2024年全球内视镜手术设备市场规模将达109亿美元,预计2030年将达到155亿美元,预测期内复合年增长率为6.1%。
内视镜手术设备是指内视镜手术过程中诊断、治疗和监测器官和腔道状况的专用工具。这些器械包括镊子、剪刀、勒除器、抓紧器和基于力的器械,穿透力较低。这些器械应用于胃肠外科、风湿科、妇科等领域,以提高手术效率、缩短病患復原时间、降低手术风险。其先进的人体工学设计和功能满足特定的医疗需求,并使其适合现代内科实践。
内视镜设备持续创新
内视镜设备的持续技术创新是市场的关键驱动力,製造商专注于整合先进技术以提高影像品质和设备可操作性。这些创新使微创手术成为可能,具有更快的恢復时间和降低併发症风险等优点。透过投资研发,公司正在引入新的功能,以满足医疗保健专业人员和患者不断变化的需求,从而改善患者的治疗效果并扩大不同医疗专业的市场范围。
中枢神经系统和感染疾病风险
与内视镜手术相关的感染疾病风险是市场的主要限制。由于胆道引流不完全和器械污染等因素,ERCP 等手术可能会导致感染疾病。这种风险需要采取严格的感染控制措施,并可能增加医疗保健提供者的营运成本和复杂性。此外,由于担心感染风险,一些患者不愿接受内视镜手术,儘管设备技术取得了进步,但这可能会限制市场成长。
对微创的需求不断增加
对微创手术不断增长的需求为内视镜手术设备市场带来了巨大的机会。微创手术有很多好处,包括术后疼痛更少、恢復更快、住院时间更短。随着患者和医疗保健提供者对这些好处的认识不断增强,对内视镜解决方案的需求也不断增加。提高手术效率和患者治疗效果的技术进步进一步推动了这一趋势,推动了市场扩张。
严格的监管核准
严格的监管核准对内视镜手术设备市场构成威胁。 FDA 等监管机构实施严格的安全和品质标准,可能会减缓产品开发和市场渗透。遵守这些法规需要大量时间和资源,这可能会阻碍创新并增加製造商的成本。这些挑战可能会限制新产品的推出并减缓市场成长,特别是对于不具备广泛监管专业知识的中小企业而言。
COVID-19 大流行最初扰乱了内视镜手术设备市场,因为它推迟了择期手术并将资源转移到管理 COVID-19 病例上。结果,需求暂时减少。然而,随着医疗保健系统的适应,由于治疗的重新安排和旨在提高效率和感染控制的设备技术创新,内视镜手术的需求有所反弹。
可重复使用手术器械细分市场预计将在预测期内成为最大的细分市场
由于其成本效益和耐用性,可重复使用的手术器械预计将在预测期内占据最大的市场占有率。这些仪器受到医疗保健提供者的青睐,因为它们可以承受多次灭菌,同时保持性能。对微创手术不断增长的需求进一步增强了该领域的主导地位。因为可重复使用的器械可以提高复杂手术期间的可视化和可操作性。
胃肠外科领域预计在预测期内复合年增长率最高
胃肠外科领域预计在预测期内复合年增长率最高。这一增长背后的驱动力是全球胃肠道疾病的盛行率不断上升。内视镜工具的技术进步提高了诊断准确性和治疗效果,使这些手术更具吸引力。随着新兴市场医疗保健基础设施的改善,胃肠内视镜检查的采用预计将大幅增加。
由于其先进的医疗基础设施和需要内视镜干预的慢性疾病的高盛行率,预计北美地区在预测期内将占据最大的市场占有率。投资创新解决方案的领先市场参与者的存在进一步巩固了北美的地位。优惠的报销政策也支持先进内视镜技术的扩散。
由于先进技术的日益采用和老年人口的增加,预计亚太地区在预测期内将实现最高的成长率。对微创手术的认识不断提高以及医疗保健基础设施的改善促进了这一增长。随着对有效诊断和治疗解决方案的需求增加,亚太地区正在成为全球市场的关键成长地区。
According to Stratistics MRC, the Global Endoscopy Operative Devices Market is accounted for $10.9 billion in 2024 and is expected to reach $15.5 billion by 2030 growing at a CAGR of 6.1% during the forecast period. Endoscopic surgical devices are specialized tools for diagnosing, treating, or monitoring conditions in organs and cavities during endoscopic surgery. These devices include forceps, scissors, snares, graspers, and force-based devices, which are less penetrating. Techniques are designed to perform specific surgical tasks when used in areas such as gastroenterology, rheumatology, and gynecology; they improve surgical efficiency, reduce patient recovery time, and reduce surgical risks. Their advanced ergonomic design and function meet specific medical needs, making them relevant in modern internal medicine practice.
Continuous innovation in endoscopy devices
Continuous innovation in endoscopy devices is a key driver for the market, as manufacturers focus on integrating advanced technologies to enhance imaging quality and device maneuverability. These innovations enable minimally invasive procedures, which offer benefits such as reduced recovery times and lower risks of complications. By investing in research and development, companies introduce new capabilities that meet the evolving needs of healthcare providers and patients, thereby improving patient outcomes and expanding the market's reach across various medical specialties.
Risk of CNS and infections
The risk of infections associated with endoscopic procedures is a significant restraint on the market. Procedures like ERCP can lead to infections due to factors such as incomplete biliary drainage and contaminated equipment. This risk necessitates stringent infection control measures, which can increase operational costs and complexity for healthcare providers. Concerns about infection risks may also deter some patients from undergoing endoscopic procedures, potentially limiting market growth despite advancements in device technology.
Rising demand for minimally invasive
The rising demand for minimally invasive procedures presents a significant opportunity for the endoscopy operative devices market. These procedures offer numerous advantages, including less postoperative pain, quicker recovery, and reduced hospital stays. As awareness of these benefits grows among patients and healthcare providers, the demand for endoscopic solutions increases. This trend is further supported by technological advancements that enhance procedural efficiency and patient outcomes, driving market expansion.
Stringent regulatory approvals
Stringent regulatory approvals pose a threat to the endoscopy operative devices market. Regulatory bodies like the FDA impose rigorous safety and quality standards that can delay product development and market entry. Compliance with these regulations requires significant time and resources, potentially hindering innovation and increasing costs for manufacturers. These challenges can limit the introduction of new products and slow market growth, particularly for smaller companies lacking extensive regulatory expertise.
The COVID-19 pandemic initially disrupted the endoscopy operative devices market due to postponed elective procedures and resource diversion towards managing COVID-19 cases. This led to a temporary decline in demand. However, as healthcare systems adapted, there was a rebound in demand for endoscopic procedures, driven by rescheduled treatments and innovations in device technology aimed at improving efficiency and infection control.
The reusable operative devices segment is expected to be the largest during the forecast period
The reusable operative devices segment is expected to account for the largest market share during the forecast period due to their cost-effectiveness and durability. These devices are favored by healthcare providers for their ability to withstand multiple sterilizations while maintaining performance. The growing demand for minimally invasive surgeries further drives this segment's dominance, as reusable devices offer enhanced visualization and maneuverability during complex procedures.
The gastrointestinal surgery segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the gastrointestinal surgery segment is expected to witness the highest CAGR. This growth is driven by the increasing prevalence of gastrointestinal disorders globally. Technological advancements in endoscopic tools enhance diagnostic accuracy and therapeutic outcomes, making these procedures more appealing. As healthcare infrastructure improves in emerging markets, the adoption of gastrointestinal endoscopy is expected to rise significantly.
The North America region is anticipated to account for the largest market share during the forecast period due to its advanced healthcare infrastructure and high prevalence of chronic diseases requiring endoscopic intervention. The presence of key market players investing in innovative solutions further strengthens North America's position. Favorable reimbursement policies also support widespread adoption of advanced endoscopic technologies.
The Asia Pacific region is anticipated to register the highest growth rate over the forecast period due to increasing adoption of advanced technologies and a growing geriatric population. Rising awareness about minimally invasive procedures and improvements in healthcare infrastructure contribute to this growth. As demand for effective diagnostic and therapeutic solutions increases, Asia Pacific emerges as a key growth region in the global market landscape.
Key players in the market
Some of the key players in Endoscopy Operative Devices Market include Olympus Corporation, Boston Scientific Corporation, Stryker Corporation, KARL STORZ GmbH & Co. KG, FUJIFILM Holdings Corporation, Smith & Nephew PLC, Ethicon Endo-Surgery, B. Braun Melsungen AG, Cook Medical, Inc., Intuitive Surgical, Inc., Medtronic PLC, Hoya Corporation, Richard Wolf GmbH, Arthrex, Inc., ConMed Corporation, Ambu A/S, Cantel Medical and Hillrom.
In October 2024, Olympus announces CE approval for three cloud-based AI medical devices, enhancing clinical outcomes and operational efficiency in endoscopy, with plans for an AI-powered endoscopy ecosystem in 2025.
In October 2023, B. Braun launches its newest laparoscopic AESCULAP(R) EinsteinVision(R) 3.0 FI during International Society for Gynecologic Endoscopy (ISGE) Annual Meeting 2023 at Sanur, Bali. This latest version is equipped with 3D Fluorescence Imaging that enables imaging in real time through its three different FI overlay modes.
In February 2023, KARL STORZ announces the acquisition of 100 percent of the shares of AventaMed DAC, an Irish medical technologies company, enhancing its ENT portfolio with a breakthrough single-use medical device for tympanostomy procedures.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.